Application of Liquid Chromatography-Tandem Mass Spectrometry to Study the Effect of Docetaxel on Pharmacokinetics and Tissue Distribution of Apatinib in Mice

Siqi Feng,Jingwei Zhang,Ying Wang,Runbin Sun,Dong Feng,Ying Peng,Na Yang,Yue Zhang,Haoxue Gao,Huilin Gu,Guangji Wang,Jiye Aa,Fang Zhou
DOI: https://doi.org/10.1016/j.jchromb.2018.03.017
IF: 3.318
2018-01-01
Journal of Chromatography B
Abstract:Apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), has attracted many attentions due to its anticancer activity in various malignancies containing non-small-cell lung cancer (NSCLC). Our previous preclinical study confirmed the enhanced anti-tumor efficacy of combined treatment between apatinib and docetaxel for NSCLC. However, the effects of docetaxel on pharmacokinetics and tissue distribution of apatinib are not clear. In present study, a reliable HPLC-MS/MS method was established for determination of apatinib. This method had a good linearity in the range of 1-5000 ng/mL, and the recovery and matrix effect were 100.1-103.5%, 77.6-83.5%, respectively. Plasma exposure level of apatinib and the values of C-max. AUC(0-12h). T-1/2, and MRT were not affected by multi-dose of docetaxel. The tissue distributions (kidney, heart, lung, spleen) of apatinib in combined treatment group were lower at 0.25 h but higher at 2 h, and that in intestine and liver were not significantly changed compared with control group. However, pretreatment with docetaxel had no significant effect on AUC(0-4h) of apatinib in tissues in mice. In conclusion, plasma and tissues exposure levels of apatinib were not affected by long-termed treatment with docetaxel, indicating that docetaxel is less likely to increase the side effect of apatinib such as hypertension, hand-foot syndrome and so on.
What problem does this paper attempt to address?